A review of current developments in RNA modifications in lung cancer

Shujun Zhang1, Yafeng Liu1, Kaijie Liu1

  • 1Department of Infectious Diseases, The First Affiliated Hospital, College of Clinical Medicine, Henan University of Science and Technology, Luoyang, 471000, Henan, China.

Cancer Cell International
|October 25, 2024
PubMed

Insights

Epigenetic RNA modifications, including m6A, m5C, m7G, and m1A, are crucial in lung cancer development and drug resistance. Understanding these mechanisms offers new therapeutic targets for lung cancer treatment.

Area of Science:

  • Oncology
  • Molecular Biology
  • Epigenetics

Background:

  • Lung cancer exhibits high global incidence and mortality, with limited therapeutic benefits for many patients.
  • Acquired drug resistance diminishes the effectiveness of current targeted therapies, necessitating novel therapeutic strategies.
  • Epigenetic alterations are increasingly recognized as significant contributors to lung cancer pathogenesis.

Purpose of the Study:

  • To review the biological functions of key epigenetic RNA modifications.
  • To summarize recent advancements in understanding their roles in lung cancer development, progression, and prognosis.
  • To provide insights for identifying new therapeutic targets in lung cancer.

Main Methods:

  • Literature review of epigenetic RNA modifications in lung cancer.
  • Analysis of the roles of m6A, m5C, m7G, and m1A in cancer biology.
  • Synthesis of current research on their clinical implications.

Main Results:

  • Epigenetic RNA modifications significantly influence lung cancer initiation and advancement.
  • These modifications are implicated in the development of resistance to targeted therapies.
  • Specific modifications like m6A, m5C, m7G, and m1A show potential as prognostic biomarkers.

Conclusions:

  • Epigenetic RNA modifications represent a critical area for understanding lung cancer.
  • Targeting these modifications may overcome drug resistance and improve patient outcomes.
  • Further research into these mechanisms can guide the development of novel lung cancer treatments.

Related Concept Videos

RNA Editing02:23

RNA Editing

RNA editing is a post-transcriptional modification where a precursor mRNA (pre-mRNA) nucleotide sequence is changed by base insertion, deletion, or modification. The extent of RNA editing varies from a few hundred bases, in mitochondrial DNA of trypanosomes, to a just single base, in nuclear genes of mammals. Even a single base change in the pre-mRNA can convert a codon for one amino acid into the codon for another amino acid or a stop codon. This type of re-coding can significantly affect the...
8.9K
RNA Stability01:53

RNA Stability

Intact DNA strands can be found in fossils, while scientists sometimes struggle to keep RNA intact under laboratory conditions. The structural variations between RNA and DNA underlie the differences in their stability and longevity. Because DNA is double-stranded, it is inherently more stable. The single-stranded structure of RNA is less stable but also more flexible and can form weak internal bonds. Additionally, most RNAs in the cell are relatively short, while DNA can be up to 250 million...
33.3K
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
3.0K
lncRNA - Long Non-coding RNAs02:39

lncRNA - Long Non-coding RNAs

In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...
8.5K
Regulation of Expression Occurs at Multiple Steps02:24

Regulation of Expression Occurs at Multiple Steps

Gene expression can be regulated at almost every step from gene to protein. Transcription is the step that is most commonly regulated. This involves the binding of proteins to short regulatory sequences on the DNA. This association can either promote or inhibit the transcription of a gene associated with the respective sequence.
Transcription results in the generation of precursor (pre-mRNA) that consists of both exons and introns, which needs further processing before being translated to a...
22.5K
Regulation of Expression at Multiple Steps01:23

Regulation of Expression at Multiple Steps

The gene expression in cells is regulated at different stages: (i) transcription, (ii) RNA processing, (iii) RNA localization, and (iv) translation. Transcriptional regulation is mediated by regulatory proteins such as transcription factors, activators, or repressors—these control gene expression by initiating or inhibiting the transcription of genes. Once a precursor or pre-mRNA is produced, it undergoes post-transcriptional modification, including 5' capping, splicing, and the...
873